Value of red targets and pattern deviation plots in visual field screening for hydroxychloroquine retinopathy

JAMA Ophthalmology

Volumn 131, Issue 4, 2013, Pages 476-480

  Marmor, Michael F ^a   Chien, Fred Y ^b   Johnson, Mark W ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Southern California Permanente Medical Group   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE;

ADULT; AGED; ARTICLE; AUTOFLUORESCENCE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EXPOSURE; DRUG INDUCED DISEASE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RETINOPATHY; RETROSPECTIVE STUDY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL FIELD; VISUAL FIELD DEFECT;

ADULT; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ELECTRORETINOGRAPHY; FEMALE; HUMANS; HYDROXYCHLOROQUINE; MALE; MIDDLE AGED; RETINAL DISEASES; RETROSPECTIVE STUDIES; SCOTOMA; TOMOGRAPHY, OPTICAL COHERENCE; VISION SCREENING; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 84876275659     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2013.1404     Document Type: Article

References (10)

1. Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF; American Academy of Ophthalmology. Revised recommendations on screening for chloroquine and hy-droxychloroquine retinopathy. Ophthalmology. 2011;118(2):415-422.
2. Percival SPB, Meanock I. Chloroquine: ophthalmological safety, and clinical assessment in rheumatoid arthritis. Br Med J. 1968;3(5618):579-584.
3. Rynes RI, Krohel G, Falbo A, Reinecke RD, Wolfe B, Bartholomew LE. Ophthal-mologic safety of long-term hydroxychloroquine treatment. Arthritis Rheum. 1979; 22(8):832-836.
4. Easterbrook M, Trope G. Value of Humphrey perimetry in the detection of early chloroquine retinopathy. Lens Eye Toxic Res. 1989;6(1-2):255-268.
5. Hood DC, Bach M, Brigell M, et al; International Society For Clinical Electrophysi-ology of Vision. ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition). Doc Ophthalmol. 2012;124(1):1-13.
6. Marmor MF. Comparison of screening procedures in hydroxychloroquine toxicity. Arch Ophthalmol. 2012;130(4):461-469.
7. Pluenneke AC, Blomquist PH. Utility of red Amsler grid screening in a rheumatology clinic. J Rheumatol. 2004;31(9):1754-1755.
8. Frisén L. A versatile color confrontation test for the central visual field: a comparison with quantitative perimetry. Arch Ophthalmol. 1973;89(1):3-9.
9. Mindel JS, Safir A, Schare PW. Visual field testing with red targets. Arch Ophthalmol. 1983;101(6):927-929.
10. Johnson CA, Sample PA. Perimetry and visual field testing. In: Kaufman PL, Alm A, eds. Adler's Physiology of the Eye. 10th ed. St Louis, MO: Mosby; 2003:552-577.